argenx to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025
20 Febbraio 2025 - 7:00AM
February 20,
2025Amsterdam, the Netherlands – argenx
(Euronext & Nasdaq: ARGX), a global immunology company
committed to improving the lives of people suffering from severe
autoimmune diseases, today announced that it will host a conference
call and audio webcast on Thursday, February 27, 2025 at 2:30 PM
CET (8:30 AM ET) to discuss its full year 2024 financial results
and provide a fourth quarter business update.
A webcast of the live call may be accessed on
the Investors section of the argenx website at
argenx.com/investors. A replay of the webcast will be available on
the argenx website for approximately one year following the
presentation.
Dial-in numbers:
Belgium
32 800 50 201France
33 800
943355Netherlands
31 20 795 1090United Kingdom 44 800 358 0970United
States
1 800 715 9871Japan
81 3
4578
9081Switzerland
41 43 210 11 32
Use the access code 3810049 to join the call.
Please dial in 15 minutes prior to the live call.
About argenx
argenx is a global immunology company committed
to improving the lives of people suffering from severe autoimmune
diseases. Partnering with leading academic researchers through its
Immunology Innovation Program (IIP), argenx aims to translate
immunology breakthroughs into a world-class portfolio of novel
antibody-based medicines. argenx developed and is commercializing
the first approved neonatal Fc receptor (FcRn) blocker, globally in
the U.S., Japan, Israel, the EU, the UK, China and Canada. The
Company is evaluating efgartigimod in multiple serious autoimmune
diseases and advancing several earlier stage experimental medicines
within its therapeutic franchises. For more information, visit
www.argenx.com and follow us on LinkedIn, X (formerly known as
Twitter), and Instagram.
Media:
Ben Petokbpetok@argenx.com
Investors:
Alexandra Roy (US)aroy@argenx.com
Lynn Elton (EU)lelton@argenx.com
Grafico Azioni Argen X (EU:ARGX)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni Argen X (EU:ARGX)
Storico
Da Mar 2024 a Mar 2025
